Healthcare >> Analyst Interviews >> November 15, 2010
Ross Muken is a Senior Managing Director and heads ISI’s Life Science Tools & Diagnostics/Health Care Technology & Distribution Research Team. Mr. Muken has been recognized by Institutional Investor, Greenwich Associates, Thomson StarMine, Forbes and Bloomberg for his insightful fundamental research and highly accurate financial modeling. Prior to joining ISI in 2012, Mr. Muken held various titles in equity research at Thomas Weisel Partners and Deutsche Bank Securities Inc., where he was mostly recently a Managing Director and headed the health care services & technology team. Earlier in his career, Mr. Muken was a member of Banc of America Securities’ Mergers & Acquisitions Group. Mr. Muken graduated magna cum laude from Boston University’s School of Management in 2001. Profile
TWST: What do you cover in medical research?
Mr. Muken: I cross over a pretty wide spectrum. So it's the life science tools, it is the contract research organizations, and then outside of that in the